Treating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam

Omar Pacha, Adelaide A HebertDepartment of Dermatology, University of Texas Health Science Center, Houston, TX, USAAbstract: Advances in current understanding of the pathophysiology of atopic dermatitis have led to improved targeting of the structural deficiencies in atopic skin. Ceramide deficiency...

Full description

Bibliographic Details
Main Authors: Pacha O, Hebert AA
Format: Article
Language:English
Published: Dove Medical Press 2012-05-01
Series:Clinical, Cosmetic and Investigational Dermatology
Online Access:http://www.dovepress.com/treating-atopic-dermatitis-safety-efficacy-and-patient-acceptability-o-a9838
id doaj-181f8a757c7b4d408af732a013ce90e0
record_format Article
spelling doaj-181f8a757c7b4d408af732a013ce90e02020-11-24T21:08:55ZengDove Medical PressClinical, Cosmetic and Investigational Dermatology1178-70152012-05-012012default3942Treating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foamPacha OHebert AAOmar Pacha, Adelaide A HebertDepartment of Dermatology, University of Texas Health Science Center, Houston, TX, USAAbstract: Advances in current understanding of the pathophysiology of atopic dermatitis have led to improved targeting of the structural deficiencies in atopic skin. Ceramide deficiency appears to be one of the major alterations in atopic dermatitis and the replenishment of this epidermal component through topically applied ceramide based emollients appears to be safe, well tolerated, and effective. Recently a ceramide hyaluronic acid foam has become commercially available and increasing evidence supports its safety and efficacy in patients who suffer from atopic dermatitis.Keywords: atopic dermatitis, ceramide, Hylatopic, eczema, non-steroidal, dermatologyhttp://www.dovepress.com/treating-atopic-dermatitis-safety-efficacy-and-patient-acceptability-o-a9838
collection DOAJ
language English
format Article
sources DOAJ
author Pacha O
Hebert AA
spellingShingle Pacha O
Hebert AA
Treating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam
Clinical, Cosmetic and Investigational Dermatology
author_facet Pacha O
Hebert AA
author_sort Pacha O
title Treating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam
title_short Treating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam
title_full Treating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam
title_fullStr Treating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam
title_full_unstemmed Treating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam
title_sort treating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam
publisher Dove Medical Press
series Clinical, Cosmetic and Investigational Dermatology
issn 1178-7015
publishDate 2012-05-01
description Omar Pacha, Adelaide A HebertDepartment of Dermatology, University of Texas Health Science Center, Houston, TX, USAAbstract: Advances in current understanding of the pathophysiology of atopic dermatitis have led to improved targeting of the structural deficiencies in atopic skin. Ceramide deficiency appears to be one of the major alterations in atopic dermatitis and the replenishment of this epidermal component through topically applied ceramide based emollients appears to be safe, well tolerated, and effective. Recently a ceramide hyaluronic acid foam has become commercially available and increasing evidence supports its safety and efficacy in patients who suffer from atopic dermatitis.Keywords: atopic dermatitis, ceramide, Hylatopic, eczema, non-steroidal, dermatology
url http://www.dovepress.com/treating-atopic-dermatitis-safety-efficacy-and-patient-acceptability-o-a9838
work_keys_str_mv AT pachao treatingatopicdermatitissafetyefficacyandpatientacceptabilityofaceramidehyaluronicacidemollientfoam
AT hebertaa treatingatopicdermatitissafetyefficacyandpatientacceptabilityofaceramidehyaluronicacidemollientfoam
_version_ 1716759051365253120